Status:
WITHDRAWN
Rituximab Desensitization Therapy for Patients on the Waiting List for Kidney Transplant
Lead Sponsor:
University of Wisconsin, Madison
Collaborating Sponsors:
Genentech, Inc.
Conditions:
End Stage Renal Disease
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This is a study of patients who have a high risk of kidney rejection before kidney transplant. The hypothesis is that treatment with a medication called rituximab will make it possible for them to rec...
Eligibility Criteria
Inclusion
- Active status on a kidney transplant waiting list with positive cross match against a living donor
Exclusion
- Receipt of a live vaccine within 4 weeks prior to randomization
- Previous Treatment with Rituximab
Key Trial Info
Start Date :
July 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2008
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00167791
Start Date
July 1 2005
End Date
March 1 2008
Last Update
October 14 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Wisconsin
Madison, Wisconsin, United States, 53792